Publications (295) Juan Francisco Navarro González publications

filter_list

2025

  1. Differences in association between hypoalbuminaemia and mortality among younger versus older patients on haemodialysis

    Clinical Kidney Journal, Vol. 18, Núm. 1

  2. Predictive value of triglyceride-glucose index for the evaluation of coronary artery disease severity and occurrence of major adverse cardiovascular events

    American Journal of Physiology - Heart and Circulatory Physiology, Vol. 328, Núm. 1, pp. H14-H20

2024

  1. Consensus document on the management of hyperkalemia

    Nefrologia

  2. Evaluation of clinical events and costs associated with the addition of dapagliflozin to chronic kidney disease treatment: Cost offset analysis

    Nefrologia

  3. FGF23 as a Potential Pathophysiological Factor in Peripheral Arterial Disease Associated with Chronic Kidney Disease

    International Journal of Molecular Sciences, Vol. 25, Núm. 10

  4. Osteoporosis management in patients with chronic kidney disease (ERCOS Study): A challenge in nephrological care

    Nefrologia , Vol. 44, Núm. 2, pp. 241-250

  5. Pentoxifylline ameliorates subclinical atherosclerosis progression in patients with type 2 diabetes and chronic kidney disease: a randomized pilot trial

    Cardiovascular Diabetology, Vol. 23, Núm. 1

  6. Projecting the Population Level Burden of CKD Progression According to Urine Albumin-to-Creatinine Ratio Categories

    Kidney International Reports, Vol. 9, Núm. 12, pp. 3464-3476

  7. Projection of the clinical and economic burden of chronic kidney disease between 2022 and 2027 in Spain: Results of the Inside CKD project

    Nefrologia

  8. Risk factors for progression in KDOQI stage 3 Chronic Kidney Disease (PROGRESER study)

    Nefrologia, Vol. 44, Núm. 5, pp. 689-699

2023

  1. Association of Klotho with Coronary Artery Disease in Subjects with Type 2 Diabetes Mellitus and Preserved Kidney Function: A Case-Control Study

    International Journal of Molecular Sciences, Vol. 24, Núm. 17

  2. Associations between Inflammation, Hemoglobin Levels, and Coronary Artery Disease in Non-Albuminuric Subjects with and without Type 2 Diabetes Mellitus

    International journal of molecular sciences, Vol. 24, Núm. 18

  3. Experimental Models to Study Diabetes Mellitus and Its Complications: Limitations and New Opportunities

    International Journal of Molecular Sciences, Vol. 24, Núm. 12

  4. From cardiorenal syndromes to cardionephrology: a reflection by nephrologists on renocardiac syndromes

    Clinical Kidney Journal, Vol. 16, Núm. 1, pp. 19-29

  5. Klotho inversely relates with carotid intima- media thickness in atherosclerotic patients with normal renal function (eGFR ≥60 mL/min/1.73m2): a proof-of-concept study

    Frontiers in Endocrinology, Vol. 14

  6. Klotho, Oxidative Stress, and Mitochondrial Damage in Kidney Disease

    Antioxidants, Vol. 12, Núm. 2

  7. Mineral and bone metabolism markers and mortality in diabetic patients on haemodialysis

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 38, Núm. 11, pp. 2589-2597

  8. Pathophysiology of bone disease in chronic kidney disease: from basics to renal osteodystrophy and osteoporosis

    Frontiers in Physiology

  9. Recommendations of the Spanish Society of Nephrology for the management of mineral and bone metabolism disorders in patients with chronic kidney disease: 2021 (SEN-MM)

    Nefrologia, Vol. 43, pp. 1-36

  10. Reply to “Letter to the Editor - Consensus document on the management of hyperkalaemia”

    Nefrologia